IRIS UniCatt

Iacovelli, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 937
NA - Nord America 692
EU - Europa 474
SA - Sud America 291
AF - Africa 32
Totale 2.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 656
SG - Singapore 429
BR - Brasile 252
CN - Cina 204
SE - Svezia 137
IT - Italia 92
IN - India 84
DE - Germania 68
VN - Vietnam 67
FR - Francia 37
GB - Regno Unito 32
IE - Irlanda 29
HK - Hong Kong 26
ID - Indonesia 26
BD - Bangladesh 25
MX - Messico 18
KR - Corea 16
RU - Federazione Russa 16
PL - Polonia 13
AR - Argentina 12
CA - Canada 12
JP - Giappone 11
EC - Ecuador 9
ES - Italia 9
IQ - Iraq 9
ZA - Sudafrica 9
NL - Olanda 8
FI - Finlandia 7
TR - Turchia 7
CO - Colombia 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
SA - Arabia Saudita 5
AT - Austria 4
CI - Costa d'Avorio 4
IR - Iran 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
PK - Pakistan 3
UZ - Uzbekistan 3
GR - Grecia 2
KE - Kenya 2
LU - Lussemburgo 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
Totale 2.426
Salva come PNG Salva come JPEG
Città #
Singapore 199
Ashburn 95
Chandler 81
Hyderabad 52
Hefei 50
Beijing 46
Ho Chi Minh City 34
Los Angeles 33
New York 32
Dublin 29
Frankfurt am Main 27
Hong Kong 26
São Paulo 23
Rome 22
Jakarta 20
Seoul 16
Milan 15
Kent 14
The Dalles 13
Düsseldorf 12
Hanoi 12
Mexico City 11
Princeton 11
Tokyo 11
Boston 10
Chicago 10
Houston 9
Warsaw 9
Chennai 8
Curitiba 8
Johannesburg 8
Munich 8
Seattle 8
Atlanta 7
Brooklyn 7
Porto Alegre 7
San Mateo 7
Santa Clara 7
Stockholm 7
Wilmington 7
Dallas 6
Dearborn 6
Denver 6
Dhaka 6
Falkenstein 6
Moscow 6
Poplar 6
Nanjing 5
Orem 5
Palermo 5
Rio de Janeiro 5
Abidjan 4
Amman 4
Belo Horizonte 4
Bexley 4
Cleveland 4
Hebei 4
Jeddah 4
Lappeenranta 4
Messina 4
Mumbai 4
Phoenix 4
Portsmouth 4
Tianjin 4
Ankara 3
Augusta 3
Baghdad 3
Boardman 3
Brasília 3
Buffalo 3
Cairo 3
Cotia 3
Da Nang 3
Guaratinguetá 3
Guayaquil 3
Jiaxing 3
London 3
Maceió 3
Madrid 3
Montreal 3
Ottawa 3
Redwood City 3
São Gonçalo 3
Uberlândia 3
Vila Velha 3
Alghero 2
Amsterdam 2
Bareggio 2
Berlin 2
Betim 2
Biên Hòa 2
Bogotá 2
Bremen 2
Brescia 2
Buenos Aires 2
Canaã dos Carajás 2
Cattolica 2
Concord 2
Cotiporã 2
Cruzeiro 2
Totale 1.218
Salva come PNG Salva come JPEG
Nome #
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 107
Methylation study of the Paris system for reporting urinary (TPS) categories 104
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 97
Biomarkers of response to advanced prostate cancer therapy 95
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 94
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 93
The effect of a treatment delay on outcome in metastatic renal cell carcinoma 93
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 92
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 90
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 89
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 84
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 83
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma 79
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 76
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives 75
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer 74
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 72
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma 71
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations 67
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 66
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study 66
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients with Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial 65
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? 63
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 62
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 61
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis 60
Revising PTEN in the era of immunotherapy: New perspectives for an old story 57
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 55
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study 54
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis 53
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 51
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin 50
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study 45
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study 37
Totale 2.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 1 1 0 5 0
2021/202286 6 0 3 13 10 0 2 11 3 4 23 11
2022/2023258 54 42 13 25 30 14 17 19 26 2 10 6
2023/2024177 11 36 9 22 5 22 13 1 7 12 17 22
2024/2025702 6 4 33 10 18 18 69 30 77 124 154 159
2025/20261.189 282 90 131 310 359 17 0 0 0 0 0 0
Totale 2.480